1. Home
  2. ICLR vs FFIV Comparison

ICLR vs FFIV Comparison

Compare ICLR & FFIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICLR
  • FFIV
  • Stock Information
  • Founded
  • ICLR 1990
  • FFIV 1996
  • Country
  • ICLR Ireland
  • FFIV United States
  • Employees
  • ICLR N/A
  • FFIV N/A
  • Industry
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • FFIV Computer Communications Equipment
  • Sector
  • ICLR Health Care
  • FFIV Telecommunications
  • Exchange
  • ICLR Nasdaq
  • FFIV Nasdaq
  • Market Cap
  • ICLR 14.5B
  • FFIV 16.9B
  • IPO Year
  • ICLR 1998
  • FFIV 1999
  • Fundamental
  • Price
  • ICLR $175.83
  • FFIV $317.23
  • Analyst Decision
  • ICLR Buy
  • FFIV Hold
  • Analyst Count
  • ICLR 13
  • FFIV 11
  • Target Price
  • ICLR $210.67
  • FFIV $314.90
  • AVG Volume (30 Days)
  • ICLR 1.2M
  • FFIV 567.1K
  • Earning Date
  • ICLR 10-22-2025
  • FFIV 07-30-2025
  • Dividend Yield
  • ICLR N/A
  • FFIV N/A
  • EPS Growth
  • ICLR 13.11
  • FFIV 22.06
  • EPS
  • ICLR 9.73
  • FFIV 11.34
  • Revenue
  • ICLR $8,089,820,000.00
  • FFIV $3,024,656,000.00
  • Revenue This Year
  • ICLR N/A
  • FFIV $11.89
  • Revenue Next Year
  • ICLR $1.73
  • FFIV $3.97
  • P/E Ratio
  • ICLR $18.06
  • FFIV $27.97
  • Revenue Growth
  • ICLR N/A
  • FFIV 8.94
  • 52 Week Low
  • ICLR $125.10
  • FFIV $195.44
  • 52 Week High
  • ICLR $328.35
  • FFIV $334.00
  • Technical
  • Relative Strength Index (RSI)
  • ICLR 57.64
  • FFIV 56.23
  • Support Level
  • ICLR $174.48
  • FFIV $308.41
  • Resistance Level
  • ICLR $181.51
  • FFIV $319.10
  • Average True Range (ATR)
  • ICLR 5.15
  • FFIV 6.22
  • MACD
  • ICLR 0.16
  • FFIV -1.12
  • Stochastic Oscillator
  • ICLR 78.82
  • FFIV 45.42

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

About FFIV F5 Inc.

F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.

Share on Social Networks: